Johnson & Johnson (BMV:JNJ)

Mexico flag Mexico · Delayed Price · Currency is MXN
3,680.00
-4.18 (-0.11%)
At close: Dec 5, 2025
17.12%
Market Cap 8.85T
Revenue (ttm) 1.69T
Net Income (ttm) 461.06B
Shares Out n/a
EPS (ttm) 189.94
PE Ratio 19.20
Forward PE 18.00
Dividend 98.40 (2.67%)
Ex-Dividend Date Nov 25, 2025
Volume 30
Average Volume 791
Open 3,680.00
Previous Close 3,684.18
Day's Range 3,680.00 - 3,680.00
52-Week Range 2,836.00 - 3,830.00
Beta 0.36
RSI 54.36
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.